Literature DB >> 22481847

Widespread dermal ulcerations and bullae.

Jay Wofford1, Mahir Patel, Allison Readinger, Alan Menter.   

Abstract

Bullous pemphigoid is an autoimmune disease of the skin characterized by large, tense bullae resulting in significant morbidity in affected individuals. The diagnosis of bullous pemphigoid may present challenges due to clinical similarities with various other bullous eruptions. Frequently, epidemiological features can provide clues to the diagnosis of bullous pemphigoid, with histologic analysis commonly required for definitive diagnosis. This case study illustrates the typical clinical and histologic findings seen in bullous pemphigoid patients and briefly discusses the differential diagnosis. An in-depth understanding of the intricate pathophysiology is essential in order to educate patients. After diagnosis and appropriate workup, an array of treatment approaches, including topical and systemic corticosteroids, immunosuppressive agents, antibiotics, chemotherapeutic agents, and even monoclonal antibodies, may be utilized individually or in combination to achieve an optimal therapeutic response.

Entities:  

Year:  2012        PMID: 22481847      PMCID: PMC3310514          DOI: 10.1080/08998280.2012.11928814

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  9 in total

Review 1.  Pemphigus and bullous pemphigoid.

Authors:  H C Nousari; G J Anhalt
Journal:  Lancet       Date:  1999-08-21       Impact factor: 79.321

2.  A major role for neutrophils in experimental bullous pemphigoid.

Authors:  Z Liu; G J Giudice; X Zhou; S J Swartz; J L Troy; J A Fairley; G O Till; L A Diaz
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

3.  Guidelines for the management of bullous pemphigoid.

Authors:  F Wojnarowska; G Kirtschig; A S Highet; V A Venning; N P Khumalo
Journal:  Br J Dermatol       Date:  2002-08       Impact factor: 9.302

4.  A highly sensitive enzyme-linked immunosorbent assay for the detection of circulating anti-BP180 autoantibodies in patients with bullous pemphigoid.

Authors:  D Zillikens; J M Mascaro; P A Rose; Z Liu; S M Ewing; F Caux; R G Hoffmann; L A Diaz; G J Giudice
Journal:  J Invest Dermatol       Date:  1997-11       Impact factor: 8.551

5.  Bullous pemphigoid and malignancy.

Authors:  L J Ortíz; M Vázquez; J L Sánchez
Journal:  Bol Asoc Med P R       Date:  1990-10

6.  A 230-kD basic protein is the major bullous pemphigoid antigen.

Authors:  S Mueller; V Klaus-Kovtun; J R Stanley
Journal:  J Invest Dermatol       Date:  1989-01       Impact factor: 8.551

Review 7.  Autoimmune bullous dermatoses: a review.

Authors:  Kelly Bickle; Tom R Roark; Sylvia Hsu
Journal:  Am Fam Physician       Date:  2002-05-01       Impact factor: 3.292

8.  Role of methotrexate in the treatment of bullous pemphigoid in the elderly.

Authors:  Timothy Patton; Neil Korman
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

9.  Bullous pemphigoid and pemphigus vulgaris--incidence and mortality in the UK: population based cohort study.

Authors:  S M Langan; L Smeeth; R Hubbard; K M Fleming; C J P Smith; J West
Journal:  BMJ       Date:  2008-07-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.